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ABSTRACT 
MIXED-EFFECTS MODELS FOR MODELING 
CARDIAC FUNCTIONS AND TREATMENT EFFECTS 
Hyejeong Jang 
April 15, 2011 
Mixed-effects model is an efficient tool for analyzing longitudinal data. The random 
effects in mixed-effects model can be used to capture the correlations among repeated 
measurements within a subject. The time points are not fixed and all available data can be 
used in mixed-effects model provided data are missing at random. For this reason, we 
focus on applying mixed-effects models to the repeated measurements of cardiac function 
including heart rate, left ventricle developed pressure, and coronary flow in the 
Glutathione-S-transferase P (GSTP) gene knockout and wild-type mice following 
ischemialreperfusion injury performed in the isolated, Langendorff-perfused heart. 
Cardiac function is measured during three time periods: pre-ischemia, ischemia (no flow), 
and reperfusion. We developed piecewise nonlinear mixed-effects model to describe the 
different aspects of the cardiac function during each period. We applied nonlinear mixed-
effects models and a changing point model to examine how cardiac function was altered 
by ischemialreperfusion-induced injury and for comparison between mouse strains. 
These findings provide evidence of a new application for the mixed-effects model in 
physiological and pharmacological studies of the heart. 
iv 
TABLE OF CONTENTS 
PAGE 
ACKNOWLEDGEMENTS .................................................................. 111 
ABSTRACT ..................................................................................... IV 
LIST OF TABLES...... .................. ....................................... ............... V11 
LIST OF FIGURES............................................................................ IX 
CHAPTER 1. INTRODUCTION ............................................................ . 
1.1 Longitudinal data analysis .......................................................... 1 
1.2 Mixed-effects models ............................................................... 2 
CHAPTER 2. MODELS AND METHODS................................................ 5 
2.1 Linear mixed-effects (LME) models ........ ................ ............ .......... 5 
2.2 Nonlinear mixed-effects (NLME) models ... ...... ......... ............ ... ... ... 8 
2.3 Method of estimation of change point in two phase growth models ......... 11 
2.4 Model selection...................................................................... 12 
CHAPTER 3. APPLICATIONS ............................................................. 15 
3.1 Experimental data and graphical presentation ...... .................. ............ 16 
3.2 Nonlinear model and statistical analysis for heart rate ........................ 17 
3.3 Nonlinear model and statistical analysis for coronary flow.. .............. ..... 29 
3.4 Nonlinear model and statistical analysis for left ventricle (LV) developed 
pressure................................................................................ 34 
CHAPTER 4. DISCUSSIONS AND CONCLUSIONS ................................... 39 
REFERENCES .................................................................................. 41 
v 
APPENDICES .................................................................................. 43 
A Linear mixed-effects model for single period..................................... 43 
B R code for this thesis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .... 49 
CURRICULUM VITAE....................................................................... 67 
vi 
LIST OF TABLES 
TABLE PAGE 
1. Estimates of fixed-effects and variance components for linear mixed-effects 
model for heart rate during pre-ischemia.. ................................ ............... 20 
2. Estimates of fixed-effects and variance components for nonlinear mixed-effects 
model (E 3.2) for heart rate during ischemia... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 22 
3. Estimates of fixed-effects and variance components for nonlinear mixed-effects 
model (E 3.3) for heart rate during reperfusion .................. ............ .......... 24 
4. Estimates of fixed-effects and variance components for the integrated mixed-effects 
model (E 3.4) for heart rate ................................................................ 26 
5. Estimates of fixed-effects for the integrated mixed-effects model (E 3.5) for coro-
nary flow ................................................................................. 31 
6. Estimates of variance components for the integrated mixed-effects model (E 3.5) 
for coronary flow......... .............. ..... ... ...... .......... ...... ... ... ............... 32 
7. Estimates of fixed-effects and variance components for nonlinear mixed effects 
change point model (E 3.6) for left ventricle (LV) developed pressure during 
reperfusion ................................................................................. 36 
8. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for heart rate 
during pre-ischemia...................................................... .................. 47 
9. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for heart rate 
during ischemia ............................ . . . . . . ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 
vii 
10. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for heart rate 
during reperfusion .......................................................................... 47 
11. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for coronary flow 
during pre-ischemia.................................................. ....................... 47 
12. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for coronary flow 
during reperfusion ......................................................................... 48 
13. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for LV develop-
ed pressure during pre-ischemia ................................................... 48 
14. Estimates of fixed-effects for linear mixed-effects model (E 3.1) for LV develop-
ed pressure during reperfusion ........................................................... 48 
viii 
LIST OF FIGURES 
FIGURE PAGE 
1. Individual profile for heart rate .......................................................... 17 
2. Individual profile for coronary flow ..................................................... 18 
3. Individual profile LV developed pressure.............................................. 18 
4. Plots of the fitted heart rates at group-level and the predicted heart rates at subject 
-level, as well as the observed heart rates (circles) versus time during ischemia. 22 
5. Plots of the fitted heart rates at group-level and the predicted heart rates at subject 
- level, as well as the observed heart rates versus time during reperfusion ........ 24 
6. Diagnostic plot: Standardized residuals versus subject-level fitted heart rates.... 27 
7. Plots of the fitted heart rates at group-level and the predicted heart rates at subject-
level, as well as observed heart rates (circles) versus time for the entire experi-
mental data............................................. .................. ............ ........ 27 
8. Fitted and observed heart rates versus time......................................... .... 28 
9. Diagnostic plot: Standardized residuals versus subject-level fitted coronary flows ... 32 
10. Plots of the fitted coronary flows at group-level and the predicted coronary flows 
at subject-level, as well as the observed coronary flows (circles) versus time for 
the entire experimental data ... . . . .. . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . .. 33 
11. Fitted and observed coronary flows versus time....................................... 33 
12. Fitted and observed LV developed pressures versus time during reperfusion.. 37 
13. Plots of the fitted LV developed pressures at group-level and the predicted LV 
ix 
developed pressures at subject-level, as well as observed LV developed pressures 
(circles) versus time during reperfusion ................................................ 37 
14. Heart rates versus time during pre-ischemia.......................................... 43 
15. Heart rates versus time during ischemia ... ......... ......... .................. ... ..... 43 
16. Heart rates versus time during reperfusion ........................................... 44 
17. Coronary flows versus time during pre-ischemia.................................... 44 
18. Coronary flows versus time during reperfusion ....................................... 45 
19. Left ventricle (LV) developed pressures versus time during pre-ischemia...... 45 
20. LV developed pressures versus time during ischemia.................. ............. 46 




1.1 Longitudinal data analysis 
Longitudinal studies are defined by having an outcome variable that is repeatedly 
measured over time. In a longitudinal study, the outcome variable is measured in a 
subject on several different occasions [1]. Longitudinal studies have been used to study 
the impact of disease and treatment methods in medicine, to find the cause of the 
development of children and the clinical progress of patients in psychology, and to study 
the causes of the behavior change in the behavioral sciences [2]. 
A longitudinal study has several advantages. First, repeated measurements from the 
same subject are not completely correlated [3], thus, repeated measures increase 
statistical power for same or smaller sample size. For this reason, longitudinal studies 
have more power than cross-sectional studies for a fixed number of subjects [3]. Second, 
in a longitudinal study, each subject can serve as his or her own control [3]. The 
exclusion of between-subject variability from measurement error leads to more efficient 
estimators for parameters related to treatment effects [3]. Third, aging effects (i.e., 
changes over time within subjects) can be separated from cohort effects (i.e., differences 
among subjects at at baseline) [3]. As a result, the individual change of a certain outcome 
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variable over time can be studied in longitudinal studies [1]. 
The key feature of longitudinal data is that repeated measures on the same subject 
are not independent. Therefore, the correlation within a subject must be accounted for 
using a specific statistical method. Repeated measures analysis of variance (repeated 
measures ANOV A) and multivariate ANOV A (MANOV A) are two traditional 
approaches for analyzing longitudinal data [3]. Repeated measures ANOV A is also called 
a mixed-effects ANOVA, where a single random subject effect is included to account for 
the correlation among the repeated measurements within the same subject [4]. However, 
the repeated measures ANOVA requires that all individuals have a complete balanced 
data set and a fixed time schedule, and treats time as a categorical variable [5]. The 
advantage of the MANOV A approach versus the ANOV A approach is that the 
MANOVA assumes a general form for the correlation of repeated measurements over 
time, while ANOVA assumes a much more restrictive compound-symmetric form [3]. 
However, MANOV A model has a limitation because it requires complete data [3]. In 
addition, both MANOV A and ANOV A models provide no information about subject-
specific growth curve [3]. Due to these reasons above, covariance pattern models, 
generalized estimating equations (GEE) models, and mixed-effects models are generally 
used for longitudinal data [3]. 
1.2 Mixed-effects models 
Mixed-effects models are widely used method for analyzing longitudinal data. 
Mixed -effects models have been developed and described under various names [3]: random 
2 
effects models [6], variance component models [7], multilevel models [8], hierarchical 
linear models [9], two-stage models [10], random coefficient models [11], mixed models 
[12], empirical Bayes models [13], and random regression models [14]. A mixed-effects 
model has a regression form as linear regression or nonlinear regression, where the 
coefficients are expressed as summation of fixed effects and random effects. The time 
points for the measurements of each subject may vary. In a mixed-effects model, random 
effects are often included to describe the subject-specific effect, and fixed effects are 
included to describe population-level effect. The correlation between the repeated 
measurements is captured by the random effects and their distribution assumption. The 
magnitude of the variance of the random effects captures the between-subject variation. 
Therefore, mixed-effects models provide a more flexible covariance structure for 
nonconstant within-subject correlation [15], and have the ability to accommodate missing 
and imbalanced data which are common in longitudinal data [5]. 
In many longitudinal analyses, change is assumed to be steady and incremental so 
that a linear model is appropriate [16]. However, in numerous situations, the change is 
not uniform but rather faster during some periods and slower in others [16]. In these cases, 
nonlinear mixed-effects (NLME) models are more appropriate than linear mixed-effects 
(LME) models to describe these nonlinear changes. A NLME model is usually 
established based on some mechanistic considerations, and its parameters usually are 
interpretable. NLME models are often used due to interpretability, parsimony, and 
validity beyond the observed range of the data [17]. Furthermore, a nonlinear model 
generally uses fewer parameters than a competitor linear model, providing a more 
parsimonious description of the data and more reliable predictions for the response 
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variables [17]. 
Based on Cudeck and Harring [16], the best way to select an appropriate NLME 
model is to graph data from an individual and examine the performance of candidate 
functions. In lieu of a theoretical rationale that favors a specific form, model choice is 
made based on the bases of goodness of fit, interpretability of the parameters, and 
appropriateness of the functional form to the situation in which it is applied. 
In this thesis, we applied mixed-effects models and change point model to 
experimental longitudinal data. The experiments were carried out in Dr. Conklin's 
laboratory to examine the impact of Glutathione-S-transferase P (GSTP) on the recovery 
of postischemic cardiac function including heart rate, left ventricle (LV) developed 
pressure, and coronary flow in the Glutathione-S-transferase P (GSTP) gene knockout 
(KO) and wild-type (WT) mice following ischemialreperfusion injury performed in the 
isolated, Langendorff-perfused heart. Cardiac function was measured during three time 
periods: pre-ischemia, ischemia (no flow), and reperfusion periods. For this study, we 
developed piecewise nonlinear function to describe the different aspects of the cardiac 
function during each period. We applied nonlinear mixed-effects models and changing 
point model to examine how cardiac function was altered by ischemialreperfusion-
induced injury and for comparison between mouse strains. The Wald test and the Akaike 
information criterion (AIC) were applied to obtain a parsimonious model for each aspect 
of cardiac function. 
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CHAPTER 2 
Models and Methods 
2.1 Linear mixed-effects (LME) models 
The linear mixed- effects (LME) model can be written as: 
Yi = Xdi + Zibi + ci , (E 2.1) 
where (Xi, Zi, Yi) ( i= 1, ... , N) are the observations for i th subject. Specifically, Xi is 
the ni x P covariate matrix associated with the fixed effects p, where p E RPxl, Zi is 
the ni x r design matrix associated with the random effects bi , where bi E RTX1, Yi is 
the ni x 1 vector of response variable, and Ci is ni x 1 within-subject error vector. The 
random effects bJi=1, ... ,N) are assumed to be independent and identically distributed 
(i.i.d.) asN(O,D), andci (i=1, ... ,N) are assumed to be i.i.d. as ci'-N(O,a2InJ, andbi 
and ci (i= 1, ... , N) are independent. As a result, it can be shown that the observation Yi 
and random effects bi follow the joint multivariate normal distribution: 
(E 2.2) 
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Estimation in LME models 
The parameters in the LME models are generally estimated by maximum likelihood 
(ML) method or restricted maximum likelihood (REML) method. Under the distribution 
assumptions for random effects b i and random errors Ci (i=J, ... ,N), the response variable 
for ith subject (i.e., Yi) has mean and variance as follows: 
E(YD = Xil3, 
In case Xi(8) = Xi is known, the ML estimate ofthe fixed effects ~ is: 
(E 2.3) 
However, the variance component parameters, i.e., the parameters in the variance of hi 
(say D) and the variance Ci (say a2 ), are unknown and need to be estimated by ML 
method or REML method. Let us denote the variance component parameters as 8, and 
their estimator as e. Then the ML estimate of the fixed effects f3 is estimated by the 
following equation (E 2.4), where Xi in (E 2.3) is replaced by Xi(e) : 
(E 2.4) 
Generally, the REML estimator for the variance component in Xi is recommended 
because the REML estimate provides unbiased estimators for variance components [18]. 
In this thesis, we use REML method to obtain estimates of variance components in LME 
model (E 2.1) and then obtain the estimates of the fixed-effect parameters as in (E 2.4) 
[19]. 
6 
Statistical inference in LME models 
Hypothesis tests are very important to examme whether certain covariates 
significantly contribute to the response variable, and whether certain parameters are the 
same, which may indicate no treatment effect. The associated statistic null hypothesis is 
Ho: A'{J = 0, and the alternative hypothesis is H1 : A'{J =1= o. 
If the underlying assumptions for the random effects hi and within-subject errors ci 
(i= 1 ... N) hold, the ML estimator of {J, say p, follows the following normal distribution: 
The test statistic for testing H 0: A '{J = 0 versus H 1: A '{J =1= 0 can be carried out using the 
Wald test statistic: 
A special case for testing Ho: {Jk = 0 versus H1 : {Jk =1= 0 can be carried out using the 
Wald test statistic: 
An alternative to test for the hypothesis is the likelihood ratio test (LRT). The LRT 
for Ho: A'{J = 0 versus H1 : A'{J =1= 0 is obtained by comparing the maximized log-
likelihoods for two models: the full model versus the reduced model. The reduced model 
incorporates the constraint that A'{J = 0, while the full model does not (i.e., without the 
7 
constraint A'P = 0) [18]. The LRTs can also be used for hypothesis tests about the 
covariance components [18]. However, the REML method can be used to compare nested 
models only involving the reduction in covariance components but should not be used to 
compare nested regression models for reduction in fixed-effects terms [18]. 
2.2 Nonlinear mixed--etTects (NLME) models 
The general formula of the single level NLME models is proposed by Lindstrom and 
Bates [6]. At first level the /h observation on the ith subject is modeled as: 
Yij = t(¢ij, vij) + cij i = 1, ... ,N, j = 1, ... ,ni' Cij -N(0,a 2 ), 
where N is the number of subjects, ni is the number of observations on the ith subject, t 
is a real-valued differentiable function of a subject specific parameter vector ¢ij, and 
covariate vector Vij, and Cij is a normally distributed within-subject error term. The 
function t is nonlinear in at least one component of the group-specific parameter vector 
¢ij, which is modeled as: 
¢ij = AijP + Bijbi , bi -N(O, 1Jl), 
where P is a p-dimensional vector of fixed effects, and bi is a q-dimensional random 
effects vector associated with the ith subject with variance-covariance matrix 1Jl. The 
matrices Aij and Bij are of appropriate dimensions and depend on the ith subject and 
possibly on the values of some covariates at the /h observation. Again here, bi and 
cij = (CiV ... , Cin)T are assumed to be normally distributed with mean zero and variance 
D and 1Jl, respectively. 
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Estimation in NLME models 
Different parameter estimations have been proposed in the NLME model [17]. In 
this thesis, we will describe methods based on the likelihood function. There are three 
methods for approximating the likelihood function in the NLME model; the LME 
approximation proposed by Lindstrom and Bates, the method of using Laplacian 
approximation to the likelihood function, and the method of using an adaptive Gaussian 
quadrature rule to improve the Laplacian approximation [17]. A REML method using the 
alternating algorithm was also proposed by Lindstrom and Bates [15]. Of these methods, 
the alternating algorithm of Lindstrom and Bates is used for estimation and inference in 
our nonlinear models. The estimation algorithm of Lindstrom and Bates for the single-
level NLME model alternates two steps, a penalized nonlinear least square (PNLS) step 
and a linear mixed effects (LME) step. 
In the PNLS step, the current estimate of tl (the precision factor) is held fixed, and 
the conditional modes of the random effects bi and conditional estimates of the fixed 
effects {3 are obtained by minimizing a penalized nonlinear least squares objective 
function: 
M 
I IIYi - !iC{3,bi)W + IItlbill 2 . 
i=l 
The LME step updates the estimate of tl based on a first-order Taylor expansion of 
the model function f around the current estimates of {3 and the conditional modes of the 
random effects bi> which will be denoted by pew) and 1J[W) , respectively. 
Letting 
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w~w) = y. _ F. (new) b~W)) + x~w) new) + 2~w) b~w) 
! ! 11 P J! ! P !! ' 
the appropriate log-likelihood function used to estimate !1 is: 
Lindstrom and Bates also proposed a REML estimation method for !1, which consists 
of replacing the log-likelihood in the LME step of the alternation algorithm by the log-
restricted-likelihood. The algorithm alternates between the PNLS and LME steps until a 
convergence criterion is met. The algorithm has been implemented by Lindstrom and 
Bates [15] in R, which can be called by function nlme in R. 
Statistical Inference in NLME models 
Inference on the parameters of an NLME model estimated via the alternating algorithm is 
based on the LME approximation to the log-likelihood function. At the convergence, 
under the normality assumption for the random effects and within-subject errors, the 
estimator P has the following distribution: 
A 2 ~T -1 ~ ( 
M -1) 
P-N p,(J [~X, E, Xi] , 
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The test statistic for testing Ho: A'f3 = ° versus H1 : A'f3 '* ° can be carried out using the 
Wald test statistic: 
A'(J 
z = -N(O,l). 
JA'COV((J)A 
A special case for testing Ho: 13k = ° versus H1: 13k '* ° can be carried out using the 
Wald test statistic: 
z = ~ -N(O,l). 
--.J Var(f3k) 
2.3 Method of estimation of change point in two phase growth models 
Suppose the growth model contains two growth phases: f1 (t; 131) at the first phase 
where t :5 yand f2(t; 132) at the second phase where t ~ y. Let us denote yet) as the 
response variable at time, then yet) is expressed as: 
if t :5 Y 
if t ~ y. 
Y is the unknown time where the growth curve from the first phase shifts to the secondary 
phase. y is called the change point [22]. 131 and 132 are unknown parameters in the phase 1 
and phase 2 curves, respectively. The continuous change implies f1 (y; 131) = f2 (y; 132)' 
To search for the change point, the least squares estimate (LSE) is obtained. 
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An algorithm for calculating a least squares estimate (LSE) 
Let us denote (ti, Yi) (i = 1, ... , n) as n observations, ordered in such a way that 
tl ~ t2 ~ ... ~ tn. We assume that the unknown change point y belongs to a given 
interval r = [y, y ]. F or the change point y E r, there exists a natural number 
m(y) with 2 ~ m(y) ~ n - 1 such that the first m(y) observations (ti,ya, (i = 
1 , ... , m(y)) belong to phase 1 and the last (n - m(y)) observations (ti, ya, (i = 
m(y) + 1, ... , n) belong to the phase 2. m(y) depends on the unknown change point y 
and y satisfies tm(y) ~ Y ~ tm(y)+l ,where m(y) is called change index. The LSE for 
model parameters (f3v f32, y) is defined as the solution of minimizing the following sum 
of squares: 
m(y) n 
S(f3Vf32'y) = I (y(ti) - fl(ti;f31))2 + I (y(ta - f2(ti;f32))2, 
j=l i=m(y)+l 
under the restriction fl (y; f31) = f2 (y; f32)' 
The detailed descriptions for the estimation change point are found in Schulze [19]. 
2.4 Model selection 
Likelihood Ratio Test (LRT) 
The likelihood ratio test (LRT) can be used to compare nested models. The LRT 
statistic is obtained as: 
LRT = 2(log LtUll - logLreduced)' 
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where log LfUll and log Lreduced are the maximized log-likelihood values for the full and 
reduced models, respectively. LRT is compared to the chi-square distribution with 
degrees of freedom being the number of additional parameters in the full model versus 
the reduced model. In this thesis, we start from a full model. Then we apply the LRT and 
the following Akaike Information Criterion (AIC) to remove the least significant term 
using a backward procedure, and obtain a parsimonious model for the final interpretation. 
Akaike Information Criterion (AIC) and Baysian Information Criterion (BIC) 
Akaike Information Criterion (AIC) is used to compare models that are not nested 
and defined for a given model as [20]: 
AIC = -2logL + 2p, 
where p is the number of parameters in the model, and the L is the likelihood function at 
the estimated parameters. 
The model with the smallest AIC value is preferred. The adjustment in AIC to the 
deviance is often called the penalty for using additional parameters in model fitting. 
Another criterion for model selection is the Baysian Information Criterion (BIC) [21]. 
This criterion is defined as: 
BIC = -2logL + plogN , 
where N is the number of observations, p is the number of parameters in the model, and 
the L is the likelihood function at the estimated parameters. 
As in AIC, the model with the lowest BIC value is preferred. The detailed descriptions 
13 




In this section, we applied mixed-effects models and change point model to 
investigate the contribution of Glutathione-S-transferase P (GSTP) gene on the recovery 
of post-ischemic cardiac function. As a member of a large family of GSTs [23], GSTP is 
a major cardiovascular GST isoform and accounts for 20-50% of the total GST activity in 
mouse aorta [24] and heart [25]. To examine the impact of GSTP on postischemic cardiac 
function, the experiments were carried out in Dr. Conklin's laboratory. Cardiac function 
was assessed by measurements of heart rate, coronary flow, and left ventricle (LV) 
developed pressure. To examine the effect of the deletion of the GSTP gene in 
myocardial ischemia-reperfusion (I1R) injury, the cardiac function of knockout (KO) 
mice was compared with wild-type (WT) mice. Each aspect of the cardiac function data 
was collected during three time periods: pre-ischemia, ischemia, and reperfusion periods. 
We developed piecewise nonlinear mixed-effects model to describe the different aspects 
of the cardiac function, and applied the nonlinear mixed-effects models, change point 
model, and model reduction techniques to obtain a parsimonious model for the final 
interpretation. We performed hypothesis tests to examine the impact of deletion of GSTP 
for different aspects of cardiac function including testing whether cardiac function 
15 
including testing whether cardiac performance eventually recovers during reperfusion 
period. 
3.1 Experimental data and graphical presentation 
Experimental Data 
Data were obtained from Glutathione-S-transferase P (GSTP) gene KO mice and WT 
mice hearts. Three different datasets were obtained for three response variables: namely, 
measurements of heart rate, coronary flow, and LV developed pressure. Cardiac function 
was measured in hearts exposed to ischemialreperfusion injury by subjecting isolated 
hearts to 5 minutes of pre-ischemia, 30 minutes of global ischemia and 45 minutes of 
reperfusion in six KO and seven WT hearts. The measurements of each one of the three 
response variables are presented in Figures 1,2, and 3, respectively. 
Graphical presentation 
Figures 1 to 3 show how the heart rate, coronary flow, and LV developed 
pressure change over different time periods for GSTP KO mice and WT mice. As 
illustrated in Figures 1 to 3, there was no significant difference between WT mice and 
KO mice during pre-ischemia for each one of the three endpoints. Figure 1 indicates 
that during reperfusion, heart rate returned to the pre-ischemic range in WT mice but 
was greater than the pre-ischemic range in KO mice. Figure 2 indicates that the 
recovery of coronary flow was better in WT mice than KO mice during reperfusion. 
Figure 3 shows that L V developed pressure started to increase after a few minutes of 
16 
perfusion in both WT and KO mice and recovered to a much greater extent in WT 
mice than KO mice. Figure 3 also indicates that ischemialreperfusion injury 
significantly decreased LV developed pressure. 
3.2 Nonlinear model and statistical analysis for heart rate 
The measurements of heart rate over time in different periods for each individual are 
presented in Figure 1. We first carry out the analysis for each one of the three time period 
separately, then we build an integrated model to describe the heart rate over time for the 
entire experiment. Hypothesis tests are carried out to examine whether the heart rate in 
WT mice is significantly different from that in GSTP KO mice, and whether the heart 
rate during reperfusion recovers to the level of pre-ischemia. 
= , = , U") , , 
~ Ischemia --7:'" Reperfusion 
= = oq-
~ = a.. = 
~ 
C0 




0 20 40 60 80 
Time (min) 






































, , , 
fE--- Ischem ia 
20 
R eperfus ion 
40 6 0 
T ime (m ilo} 
Figure 2. Individual profile for coronary flow. 
20 
, , , , , , , , 
~:ooEE---
40 
T ime (mi n) 
Reperfus ion 
60 









Model and analysis of heart rate during pre-ischemia 
To examine the heart rate during pre-ischemia, we started with a full linear mixed-
effects model with the following form: 
(E 3.1) 
where Yij is the measurement of heart rate for subject i at time tij (i = 1, ... , N), 
if mouse i is knockout 
if mouse i is wild - type. 
The fixed effect parameters are Po, Pv Pz, and P3' Po is the mean of the heart rate of 
WT mice at the starting point (i.e., tij = 0); Pi describes the change rate of the heart rate 
for WT mice during pre-ishemia; pz is the mean difference of the heart rates of the KO 
mice versus WT mice at the starting time of the experiment; P3 is the slope difference of 
the heart rates between KO mice versus WT mice. The random effect bOi (i = 1, ... , N) 
describes the deviation of the heart rate of ith subject away from its group average at time 
tij = 0, and b1iCi = 1, ... ,N) is the deviation of the slopes for ith subject away from its 
group-level slope. 
We start from the full model (E 3.1), and then the least significant term was removed 
using the Wald test and AIC. The process was repeated until the AIC reaches its 
minimum. As a result, we could remove time and interaction terms in the fixed effects 
but could not remove the two random effects. Type in fixed effects (say, PzJ was not 
significant. However, we kept this parameter for testing whether or not heart rate is 
significantly different between the pre-ischemia and reperfusion period for both WT mice 
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TABLE 1 
Estimates of fixed-effects and variance components for linear mixed-effects model for 
heart rate during pre-ischemia 
Parameter Estimate 95% C.l. Z P- value 
Po 295.61 [260.67,330.55] 18.17 0.00 
pz 14.72 [-41.69, 71.13] 0.61 0.55 
ao 78.73 [51.87,119.49] 
a1 12.49 [8.23, 18.95] 
P -0.82 [-0.94, -0.49] 
a 11.45 [9.17, 14.30] 
and KO mIce. Table 1 shows the estimates of the fixed-effects and the varIance 
components for the final model for pre-ischemia period. 
The linear mixed-effects model (E 3.1) was applied to pre-ischemia, ischemia, and 
reperfusion periods, respectively, for each aspect of cardiac function. The results are 
presented in Appendix A. 
Model and analysis of heart rate during ischemia 
Figure 1 shows that the pattern of heart rate change over time during ischemia is not 
linear, and resembles exponential decline. Therefore, nonlinear mixed-effects model was 
considered for accurate approximation of the response variable. We used exponential 
function of the form C1 exp( -Cz (tij - T1 )+) to describe the dynamic change of the heart 
rate during ischemia, where C1 describes the heart rate at the beginning of ischemia, 
C2 (> 0) describes the exponential decline rate, (t - T1)+ takes t - T1 if t - T1 > 0 and 
o otherwise, where T1 is a known constant, representing the time to start ischemia injury. 




typei = { 1 o 
k = 1,2, 
if mouse i is knockout 
if mouse i is wild- type. 
Cli is the value ofYij at tij = Tl and C2i is the constant exponential decline rate. 
(E 3.2) 
The fixed effect Pll represents the mean of the heart rate for WT mice at the 
beginning of ischemia, and Pll + P2l represents the mean of heart rate for KO mice at 
the beginning of ischemia. The random effect bli (i = 1, ... ,N) describes the deviation 
of the heart rate for ith subject away from its group mean. Similarly, P12 and 
P12 + P22 represent the exponential decline rate for WT mice and KO mice, 
respectively, and b2i describes the deviation of the exponential decline rate for ith 
subject from group-level decline rate. 
Nonlinear mixed-effects model (E 3.2) was fitted to the ischemia data and the 
results are given in Table 2. From Table 2, it is clear that there is no significant 
difference for the heart rate at the beginning of ischemia between the two types of 
mice. However, the exponential decline rate for WT mice is significantly larger than 
for KO mice at significant level 0.1. The fitted heart rates at group-level and the 
predicted heart rates at subject-level, as well as the observed heart rates are presented 
in Figure 4. As can be seen in Figure 4, the subject-level predictions closely matched 
the observed heart rates during ischemia indicating the goodness of fit of the model. 
Model and analysis of heart rate during reperfusion 
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TABLE 2 
Estimates of fixed-effects and variance components for nonlinear mixed-effects model 
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Figure 4. Plots of the fitted heart rates at group-level and the predicted heart rates 
at subject-level, as well as the observed heart rates (circles) versus time during 
ischemia. 
Figure 1 shows that the pattern of heart rate during reperfusion is nonlinear. 
The heart rate during reperfusion increases and reaches a plateau. The nonlinear of the 
22 
the plateau of heart rate when the time for reperfusion goes to large, and C4 is related to 
the increasing rate of heart rate during reperfusion. The nonlinear mixed-effects model to 
describe the heart rate during reperfusion can be expressed as: 
where 
typei = { 
1 
o 
if mouse i is knockout 
if mouse i is wild- type . 
(E 3.3) 
C3i is the asymptote as tij ~ 00 and C4i is the constant exponential increasing rate. 
Model (E 3.3) can be fitted by using the function SSasymOrig in R [17]. Figure 5 
shows that the fitted heart rates at group-level and the prediction heart rates at subject-
level. Nonlinear mixed-effects model (E 3.3) was fitted and the results are given in 
Table 3. An overall assessment of the quality of the nonlinear mixed-effects model (E 
3.3) is shown in Figure 5 .. As can be seen in Figure 5, subject-level predictions closely 
matched the observed heart rates during reperfusion indicating the goodness of fit of 
the model. 
An integrated mixed-effects model for heart rate during the entire experiment 
The preliminary analyses of heart rate data indicate that linear mixed-effects 
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Figure 5. Plots of the fitted heart rates at group-level and the predicted heart 
rates at subject-level, as well as the observed heart rates versus time during 
reperfusion. 
TABLE 3 
Estimates of fixed-effects and variance components for nonlinear mixed-effects model 
(E 3.3) for heart rate during reperfusion 
Parameter Estimate S.E. 95% C.1. Z P- value 
P13 276.49 23.68 [230.14, 322.85] 11.67 0.00 
P23 107.35 39.81 [29.43 , 185.26] 2.70 0.01 
P14 -1.66 0.33 [-2.31 , -1.01] -4.97 0.00 
P24 -1.09 0.52 [-2.10, -0.08] -2.11 0.04 
0'3 61.39 [21.02, 179.29] 
0'4 0.86 [0.54, 1.38] 
P -0.77 [-0.93, -0.34] 
0' 38.62 [36.29, 41.10] 
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mixed-effects models are preferred to describe the heart rate for ischemia and 
reperfusion. 
An integrated mixed-effects model for heart rate is expressed as: 
where 
Yij = { 
Cli 
C1iexp (-C2i (tij - 5)) 
C3i [1- exp( -C4i (tij - 33)+)] 
0< t·· < 5 - lJ-
5 < t·· < 33 lJ -
33 < tij :5 78 , 
k=1, ... ,4, 
typei = { 1 o 
if mouse i is knockout 
if mouse i is wild- type. 
(E 3.4) 
The interpretations of the parameters are exactly the same as those in the 
separated models. We start from the full model (E 3.4) with general variance-
covariance on random effects. The approximate 95% confidence intervals on variance-
covariance components for random effects indicate diagonal variance-covariance 
structure which covariances between the random effects are zero. To determine which 
variance-covariance structure is needed for random effects, AlC and LRT are used. As 
a result, the simpler variance-covariance structure for random effects (say, diagonal 
variance-covariance) was preferred. Table 4 shows the estimates of fixed-effects and 
the variance components for the integrated mixed-effects model (E 3.4) with diagonal 
variance-covariance structure on random effects for the entire experimental data. 
Figure 6 shows the plot of the standardized residuals versus the subject-level predicted 
values, which shows no evidence for the violation of the homogeneity of variance. An 
overall assessment of the integrated model (E 3.4) is provided by Figure 7, which indicates 
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TABLE 4 
Estimates of fixed-effects and variance components for the integrated mixed-effects 
model (E 3.4) for heart rate 
Parameter Estimate S.E. 95% C.l. Z P- value 
Pu 289.69 18.11 [254.30, 325.09] 15.99 0.00 
P21 27.59 28.06 [-27.23,82.42] 0.98 0.33 
Pu -1.10 0.05 [-1.20, -1.00] -21.55 0.00 
P22 - 0.06 0.07 [-0.21, 0.08] - 0.84 0.49 
P13 275.85 24.44 [228.08,323.62] 11.28 0.00 
P23 110.79 41.86 [28.99, 192.59] 2.65 0.01 
P14 -1.64 0.34 [-2.30, -0.98] - 4.86 0.00 






that the proposed model fit this experimental data very well. Figure 8 shows that the 
recovery of heart rate in WT mice is more stable than in KO mice during reperfusion. 
Rigorous statistic tests and inference are provided in the following subsection for the 
entire experiment. 
Statistical test and inference for heart rate 
To test whether the heart rate during reperfusion recovers to the level at pre-ischemia 
for WT mice, the underlying null hypothesis is Ho: P11 - P13 = 0 and the alternative 
hypothesis is Hi: P11 - P13 '* o. 
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Figure 7. Plots of the fitted heart rates at group-level and the predicted heart rates 
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Figure 8. Fitted and observed heart rates versus time. 
where A' = (1,0,0,0, -1,0,0,0) . 
P-value is 2P(z;:::0.389) = 0.697, which indicates that we cannot reject Ho at the 5% 
significance level. Therefore, we conclude that heart rate for WT mice during reperfusion 
recovered to the level at pre-ischemia. 
To test whether the heart rate during reperfusion recovers to the level at pre-ischemia 
for KO mice, the underlying null hypothesis is Ho: {311 + {321 - {313 - {323 = ° and the 
alternative hypothesis is H1 : {311 + {321 - {313 - {323 * 0. 





where X = 0,1,0,0,-1,-1,0,0) andP-value is2P(z2;: 1-1.7721)=0.077. 
Since P-value is 0.077, we cannot reject Ho at the 5% significance level. Therefore, 
we conclude that heart rate for KO mice during reperfusion recovered to the level at pre-
ischemia. 
3.3 Nonlinear model and statistical analysis for coronary flow 
An integrated mixed-effects model for coronary flow during the entire experiment 
The preliminary analysis of coronary flow data during reperfusion indicated that the 
change in coronary flow was significantly different in KO mice compared with WT mice. 
In addition, linear mixed-effects models are appropriate to describe coronary flow during 
pre-ischemia and ischemia and nonlinear mixed-effects model is preferred to describe 
coronary flow during reperfusion period. The integrated mixed-effects model for 
coronary flow is expressed as: 
where 
Cli 0 ~ tij ~ 5 
C2i 5 < tij ~ 33 
C3i + (C4i - c3aexp (-CSi(tij - 34)) -C7i [exp(-CSi (tij - 34)) -exp(-C6i (tij - 34)), 
33 < tij ~ 78 




k = 1, ... ,7, 
if mouse i is knockout 
if mouse i is wild - type . 
C3i is the asymptote as tij ~ 00 , C4i is the coronary flow immediately after ischemia at 
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tij = 34 and CSi and C6i are non-negative values and the logarithm of the rate constants. 
tij is a normally distributed within-subject random errors. bki (k=I, .. . ,6) are random 
effect associated with ithsubject. The fixed effect fJll and fJll + fJZl are the mean of 
the coronary flows for WT mice and KO mice during pre-ischemia, respectively; fJ12 and 
fJ12 + fJzz are the mean of coronary flows for WT mice and KO mice during ischemia, 
respectively; fJ13 and fJ13 + fJz3 represent the mean of coronary flows for WT mice and 
KO mice when the time for reperfusion goes to large, respectively; fJ14 and fJ14 + fJZ4 
are the mean coronary flows of WT mice and KO mice at the beginning of reperfusion; 
The random effect bki (i = 1, ... , N) describes the deviation of coronary flow for 
ithsubject away from its group mean. 
The integrated model (E 3.5) was fitted to the entire experimental data and the 
analysis results are given in Table 5 for estimates for fixed effects and Table 6 for 
estimates for variance components. Figure 9 shows the plot of the standardized 
residuals versus subject-level predicted values, which does not indicate any systematic 
deviation from the homogeneity of variance. An overall assessment of the integrated 
mixed-effects model (E 3.5) is shown in Figure 10. Both the fitted coronary flows at 
group-level and the predicted coronary flows at subject-level are displayed to show 
how individual effects are accounted for in the integrated mixed-effects model. As can 
be seen in Figure 10, the subject-level predictions matched the observed coronary 
flows very well for the entire experimental data indicating the goodness of fit of the 
model. Figure 11 shows that the recovery of coronary flow in WT is faster than that in 
KO mice during reperfusion. Rigorous statistical test and inference are provided in the 
following subsection. 
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Statistical test and inference for coronary flow 
To test whether the coronary flow during reperfusion recovers to the level of pre-
ischemia for WT, the underlying null hypothesis is Ho: Pll - P13 = ° and the alternative 
hypothesis is H1: Pll - P13 '* 0. 
The Wald test statistic is: 
A'P 
z = = -0.346, 
JA'COV(P)A 
where A' = (1,0,0,0, -1,0,0,0,0,0,0,0,0,0) ,and P-value is 2P(z-;::' 1- 0.3461) = 0.730. 
Because P-value is 0.730, we cannot reject Ho at the 5% significance level. Therefore, we 
conclude that the coronary flow for WT mice during reperfusion recovered to the level at 
pre-ischemia. 
TABLE 5 
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Figure 10. Plots of the fitted coronary flows at group-level and the predicted 
coronary flows at subject-level, as well as the observed coronary flows (circles) 
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Figure 11. Fitted and observed coronary flows versus time. 
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To test whether the coronary flow during reperfusion recovers to the level at pre-
ischemia for KO mice, the underlying null hypothesis is Ho: f311 + f321 - f313 - f323 = 0 
and the alternative hypothesis is H1: f311 + f321 - f313 - f323 '* O. 
The Wald test statistic is: 
z = --;:::=== 
J}.ICOV(P)}. 
2.526, 
where A' = (1,1,0,0,0,0,-1,-1,0,0,0,0,0,0) and P-value is 2P(z;:::2.526) = 0.012. 
Because P-value is 0.012, we reject Ho at the 5% significance level. Therefore, we 
conclude that the coronary flow for KO mice after reperfusion does not recover to the 
level of pre-ischemia. 
Based on the two hypothesis tests, we conclude that the recovery rate of the coronary 
flow is better in WT mice than in KO mice. 
3.4 Left ventricle (LV) developed pressure 
Figure 3 illustrates the LV developed pressure over different period of time. 
Particularly, the LV developed pressure during reperfusion was constant and increased 
exponentially. The onset point to exponential growth is called a change point. The onset 
of LV developed pressure is important since it indicates how rapidly the LV developed 
pressure starts to recover. The asymptotic value for the L V developed pressure is also 
important since it indicates the degree of recovery. We propose the following model: 
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to describe the LV developed pressure during reperfusion, where C2 is the change point, 
and Cl + C3 is the asymptotic LV developed pressure. Note that the true time of 
transition from the constant to the exponential growth is unknown for each mouse and is 
influenced by random factors, so the change point was estimated by including a random 
effect in the model [20]. We propose the following nonlinear mixed-effects change point 
model: 
where 
typei = { 1 o 
tij ~ C2i 
tij 2:: C2i , 
k = 1, ... ,4, 
if mouse i is knockout 
if mouse i is wild - type. 
(E 3.6) 
Cli is constant LV developed pressure before the onset of exponential growth, C2i 
represents the unknown transition time between the constant LV developed pressure and 
the exponential growth, Cli + C3i is the asymptotic LV developed pressure as tij ~ 00, 
and C4i is the exponential constant growth rate for the exponential LV developed 
pressure. Table 7 shows the estimated parameters and Figure 12 shows the fitted results 
for L V developed pressure during reperfusion. L V developed pressure recovered to a 
much greater extent in WT hearts than in KO hearts and there was no significant 
difference in transition time between the two types of mice. An overall assessment of the 
nonlinear mixed-effects change point model (E 3.6) is shown in Figure 13. Both the fitted 
LV developed pressures at group-level and the predicted LV developed pressures at 
3S 
subject-level during reperfusion are displayed to show how individual effects are 
accounted for the nonlinear mixed-effects change point model (E 3.6). As can be seen 
Figure 13, the subject-level predictions matched the observed LV developed pressures 
very well during reperfusion, indicating the goodness of fit of the model. 
Statistical test and inference for L V developed pressure 
P12 = 49.67 with p-value <0.01 indicates that the transition time is about 49.67-33 
= 16.67 minutes from starting reperfusion. To test whether there is a significant 
difference between WT mice and KO mice in time at the onset of the recovery in LV 
TABLE 7 
Estimates of fixed-effects and variance components for nonlinear mixed-effects change 
point model (E3.6) for left ventricle (LV) developed pressure during reperfusion 
Parameter Estimate S.E. 95% C.1. Z P- value 
fl11 3.22 0.35 [2.54, 3.90] 9.24 0.00 
fl21 -0.17 0.51 [-1.16,0.83] -0.33 0.74 
flu 49.67 1.24 [47.26,52.09] 40.15 0.00 
flzz 0.55 1.90 [-3.15,4.25] 0.29 0.77 
fl13 25.10 3.40 [18.47,31.73] 7.39 0.00 
fl23 -10.48 5.01 [-20.26, -0.70] -2.09 0.03 
fl14 -2.36 0.10 [-2.56, -2.16] -22.80 0.00 
flZ4 -0.31 0.19 [-0.68, 0.05] -1.67 0.10 
0'1 0.79 [0.48, 1.32] 
O'z 3.18 [2.05,4.95] 
0'3 8.76 [5.90, 13.01] 
0'4 0.20 [0.06, 0.65] 
P1Z -0.60 [-0.91,0.16] 
P13 0.17 [-0.44, 0.68] 
P14 0.49 [-0.54,0.93] 
P23 -0.73 [-0.93, -0.22] 
PZ4 -0.55 [-0.91,0.30] 
eH 0.04 [-0.51, 0.58] 
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Figure 12. Fitted and observed LV developed pressures versus time during 
reperfusion. 
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Figure 13. Plots of the fitted LV developed pressures at group-level and the 
predicted LV developed pressures at subject-level, as well as observed LV 
developed pressures (circles) versus time during reperfusion. 
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developed pressure during reperfusion, the underlying null hypothesis is Ho: f322 = 0 
and the alternative hypothesis is H1: f322 '* O. 
The Wald test statistic is: 
z= (322 = 0.29, 
JvarC(322) 
P-value is 2P(z2::0.29) = 0.77, which indicates that we cannot reject Ho at the 5% 
significance level. Therefore, we conclude that there is no significant difference in time at 
the onset of the recovery in LV developed pressure during reperfusion between KO-type 
and WTmice. 
To test whether the LV developed pressures between WT mIce and 
KO mice after reperfusion are significantly different, the null hypothesis is Ho: f323 = 0, 
and the alternative is H1: f323 '* O. 
The Wald test statistic is: 
z= (323 = -2.09, 
JvarC(323) 
P-value = 2P(z2::I-2.091) = 0.03, which indicates that we reject Ho at the 5% significance 
level. The results show that the asymptotic L V developed pressure during reperfusion is 
significantly higher in WT mice than that in KO mice. 
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CHAPTER 4 
Discussion and conclusions 
The defining feature of a longitudinal study is that subjects are measured repeatedly 
over time. As repeated observations made on the same subject tend to be correlated, 
longitudinal data require specific statistical methods to account for the correlation. 
Mixed-effects model is an efficient tool for analyzing longitudinal data. It provides 
covariance structure for correlated repeated measurements. Unlike traditional repeated 
measures ANOVA, the time points are not fixed and all available data can be used in 
mixed-effects model, provided data are missing at random. 
In this study, we focus on applying the mixed-effects models to the repeated 
measurements of cardiac function including heart rate, coronary flow, and left ventricle 
developed pressure in the isolated, Langendorff perfused hearts of the Gluatathione-S-
transferase (GSTP) gene KO and WT mice following ischemia! reperfusion injury. Each 
aspect of the cardiac function data consists of three time periods: pre-ischemia, ischemia, 
and reperfusion periods. We developed piecewise nonlinear mixed-effects model to describe 
the different aspects of cardiac function. We examined how cardiac function was altered 
by ischemia!reperfusion injury for KO mice and WT mice using nonlinear mixed-effects 
model and change point model. The Wald test and Akaike Information criterion (AIC) 
39 
are applied to obtain a parsimonious model for each aspect of cardiac function. The 
goodness of fit is examined, and the proposed models fit the experimental data very well. 
Nonlinear mixed-effects models provide not only interpretable models for the 
experimental data but also reliable predictions for the response variables in our 
experimental data. Therefore, nonlinear mixed-effects models are highly recommended 
for the assessment of the dynamic change of the cardiac function and the assessment of 
the treatment effect on the cardiac function. 
40 
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Estimates of fixed-effects for linear mixed-effects model (E 3.1) for heart rate during pre-
ischemia 
Parameter Estimate S.E. DF Z P-value 
Po 257.12 29.66 50 8.67 0.00 
PI 7.71 4.81 50 1.60 0.12 
pz 49.59 43.66 11 1.14 0.28 
(b -6.98 7.08 50 -0.99 0.33 
TABLE 9 
Estimates of fixed-effects for linear mixed-effects model (E 3.1) for heart rate during 
ischemia 
Parameter Estimate S.E. DF Z P-value 
Po 114.58 9.56 322 11.99 0.00 
PI - 4.38 0.45 322 - 9.67 0.00 
pz 17.00 14.81 10 1.15 0.28 
(b - 0.62 0.70 322 - 0.89 0.37 
TABLE 10 
Estimates of fixed-effects for linear mixed-effects model (E 3.1) for heart rate during 
reperfusion 
Parameter Estimate S.E. DF Z P- value 
Po 167.62 25.85 526 6.48 0.00 
PI 3.02 0.71 526 4.28 0.00 
pz - 65.31 40.06 10 -1.99 0.07 
P3 2.76 1.09 526 2.85 0.00 
TABLE 11 
Estimates of fixed-effects for linear mixed-effects model (E 3.1) for coronary flow during 
pre-ischemia 
Parameter Estimate S.E. DF Z P-value 
Po 2.86 0.27 50 10.27 0.00 
PI 0.00 0.03 50 0.01 0.99 
pz -0.26 0.41 11 -0.64 0.54 
(h -0.00 0.05 50 -0.10 0.92 
47 
TABLE 12 
Estimates of fixed-effects for linear mixed-effects model (E 3.1) for coronary flow during 
reperfusion 
Parameter Estimate S.E. DF Z P- value 
Po 4.07 0.48 570 8.52 0.00 
PI - 0.02 0.03 570 -4.42 0.00 
pz - 1.43 0.70 11 - 2.04 0.07 
P3 0.01 0.01 570 0.99 0.32 
TABLE 13 
Estimates of fixed-effects for linear mixed-effects model (E 3.1) for LV developed 
pressure during pre-ischemia 
Parameter Estimate S.E. DF Z P-value 
Po 67.52 5.47 50 12.33 0.00 
PI -1.13 0.88 50 -1.29 0.20 
pz 10.48 8.06 11 1.30 0.22 
P3 1.76 1.30 50 1.36 0.18 
TABLE 14 
Estimates of fixed-effects for linear mixed-effects model (E 3.1) for LV developed 
pressure during reperfusion 
Parameter Estimate S.E. DF Z P- value 
Po -24.01 4.07 570 -5.90 0.00 
PI 0.68 0.11 570 6.32 0.00 
pz 12.70 5.99 11 2.12 0.06 
P3 -0.32 0.16 570 -2.02 0.04 
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Appendix B: R code for the thesis 
######################################### 










for(i in I :fnum){ 
mytemp=read.csv(file=fname[i],header=T) 
temp=mytemp[as.charactcr(mytemp$period)!="",] 





val. name<-mice( I )[[2ll 








colnames{ wk )<-val.name 
index2=c{ rep{"preisch" ,5),rep{"isch" ,28),rep{"reper" ,45» 
sub.mean=data. frame{round{ wt,3 ),index2) 
type2<-c( rep("Wild", 7*78),rep("Knockout" ,6*78» 
wt2.subject<-paste(rep("WT", 7*78),rep( 1 :7,each=78),sep="") 
ko2.subject<-paste{rep{"K T" ,3 *78),rep( 1 :3 ,each=78),sep="") 
ko3 .subject<-paste(rep("K T" ,3 *78),rep{ 5:7 ,each=78),sep="") 
subject2<-c( wt2.subject,ko2 .subject,ko3 .subject) 






mydata.g$type <- relevel(mydata.g$type, ref="Wild") 
contrasts( mydata.g$type) 
###Preischemic period#### 






##Fitting linear mixed-effects model## 
pre.lme<-lme(pre.lis,random=-I) 
pre I.lme<-update(pre.lme,random=-time) 
anova(pre.lme,pre l.lme) # pre l.lme is better 
summary(prel.lme) 
pre. inter.lme<-lme{Rate-time*type,random=-time,pre) 
pre I. inter.lme<-lme(Rate-time*type,random=-time,pre,method="ML") 
pre2.lme<-lme(Rate-type,random=-time,pre,method="ML") 









pairs( isch.1 is,id=O.O I ,adj=-O .5) 
plot( intervals( isch.lis)) 
plot(isch) 




summary( isch 1.lme) 
anova(isch.lme,ischl.lme) # ischl.lme is better 
## Fitting nonlinear mixed-effects model## 
rm. isch<-isch [as.character( isch$subject)!="K I5",j 
#Finding initial value 
pd <- function(para,time){ 
para[ Ij*exp( -exp(para[2])*time) 
vstart = c(l,-15) 
td = na.omit(isch) 
id = unique(td$subj) 
allpar = cO 
for(i in I :Iength(id)){ 
aa = td[td$subj==id[ij,j 
aa$time = aa$time-6 
fun <- function(par){ 
#par = exp(par) 
fit = pd(para=par,time=aa$time) 
11= sum( (aa$Rate-fit)"2 ) 
II 
fit = nlminb(start=(vstart),fun) 
pred = pd(fit$par,time=seq(0,50,by=.I)) 
Sl 
dev.newO 
plot( seq(O,50,by=.1 ),pred,col=2,type="I" ,ylim=c(O,341 )) 
points( aa$time,aa$Rate) 
title(paste("Subj:",id[iJ,sep="")) 
allpar = rbind(allpar,fit$par) 
nlstart = apply(allpar,2,mean) 
isch. type.nlme<-nlme(Rate-Asym 1 *exp( -exp(xmid)*time), 
fixed= Asym 1 + xmid -type, 
random = Asym I + xmid -I, 
#groups=-type, 
start=c(Asyml =nl start[1 ],O,xmid=n Istart[2],O), 
control=list(maxIter=1 O,pnlsMaxIter= 1 O,tolerance=O.1 ,niterEM= 1 O,pnlsTol=O.I,msTol=O.O I), 
data=rm.isch) 
summary( isch. type.nlme) 
plot(augPred(isch.type.nlme,levei = 0: I), 






plot(per,xlab="Tme(min)-Reperfusion period",ylab="Heart Rate(BPM)") 
##Fitting linear mixed-effects model## 
perl.lme<-lme(Rate-time*type,per,na.action=na.omit,random=-timelsubject) 
summary(per l.lme) 
plot(augPred(perl.lme),grid = T) 
plot(per) 
##Fitting nonlinear mixed-effects model## 
#remove K05 
rm. per<-per[ as.character(per$subject)!="K T5" ,j 
rm.per = na.omit(rm.per) 
names(rm.per) 
#Finding initial value 
pd <- function(para,time){ 
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SSasympOrig(time, para[I],para[2]) 
vstart = e(287,-2) 
td = rm.per 
id = unique(td$subj) 
all par = cO 
for(i in I: length(id»){ 
aa = td[td$subj=id[i],] 
aa$time = aa$time 
fun <- funetion(par){ 
fit = pd(para=par,time=aa$time) 
11 = sum( (aa$Rate-fit )"2 ) 
11 
fit = nlminb(start=(vstart),fun) 
pred = pd(fit$par,time=seq(0,50,by=.l» 
dev.newO 
plot( seq(0,50,by=.1 ),pred,eol=2,type="I" ,ylim=e(0,500» 
points( aa$time,aa$Rate) 
titIe(paste("Subj:" ,id[i],sep=""» 
allpar = rbind(allpar,fit$par) 
n2start = apply(allpar,2,mean) 
n3.type.rm.nlme<-nlme(Rate-SSasympOrig(time, Asym,lre), 
data=rm.per, 
fixed = Asym + Ire - type, 
random = Asym + Ire - I, 
start=e(Asym = n2start[l],0,lrc = n2start[2],0), 
eontrol=list(pnlsMaxIter= 1 0) 
summary(n3.type.rm.nlme) 
plot(n3.rm.nlme) 




### The integrated model for heart rate ### 
pre. isch. per <- mydata.g[ as.character(mydata.g$subject)!="K T5" ,j 
names(pre.isch.per) 
IntModel2 <- function(time,CI ,C2,C3,C4){ 
CI*(time<=5)+ CI *exp(-exp(C2)*(time-5»*(time>5 & time<=33)+as.numeric(SSasympOrig«time-33), 
Asym=C3,lrc=C4»*(time>33) 
integrate2 .nlme<-nlme(Rate-IntModeI2(time,C 1 ,C2,C3 ,C4), 
na.action=na.omit, 
fixed = C 1 +C2+C3+C4 - type, 
random = CI+C2+C3+C4 - I, 










bb=rownames(pre. isch. per. mat) 
wi=which(unlist(gregexpr("W" ,bb »!=-1) 
ki=which( unlist(gregexpr("K" ,bb) )!=-1) 
wrate.mat=pre.isch.per.mat[wi,j 
krate.mat=pre.isch.per.mat[ki,j 
predictin<-predict(integrate2.nlme, level = 0:1) 
wt. p<-predict. in [predict. in$subject="WT 1 ",j 
wt.pp<-wt.p[,2j 
kt. p<-predict. in [predict. in$subject=="K T 1 ",j 
kt.pp<-kt.p[,2j 
plot(pre.isch.per$time,pre.isch.per[,5j,ylab="Heat Rate (BPM)", 
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xlab="Time (min)",type="n",xlim=c(I,78)) 
for(i in 1 :7){ 
points( c(l :78),wrate.mat[i,j,col=2,type="p",lwd=1 ,pch=l) 
points( c( 1 :78),krate.mat[i,j,col=4,type="p" ,Iwd= I ,pch=3) 
legend{"bottomright" ,c("WT: observation", "WT: prediction", "KO: observation", "KO: prediction"), 
col=c(2,2,4,4 ),pch=c( I ,-I ,3,-1 ),Ity=c( -1,1,-1 ,2),lwd=c( -1,3,-1,3)) 
lines (c(l:78),wt.pp,lwd=3,col=2) 
lines (c(l:78),kt.pp,lwd=3,lty=2, col=4) 
abline( v=c( 5 ,33 ),lty=2) 
arrows(l3,450, 5,450, length = 0.1) 
arrows(27,450, 32.5,450,length = 0.1) 
text(20,450, "Ischemia") 
arrows(45,450, 33.5,450, length = 0.1) 







ramda. w=c( 1 ,0,0,0,-1 ,0,0,0) 
n umer=t( ramda. w)% *%as. n umeric( integrate2. nlme$coefficients$ fixed) 
denomi=sqrt(t( ramda. w)%*%vc%*%ramda. w) 
z.value=numer/denomi 
z.value 
df. w=as.numeric(integrate2.nlme$fixDF$X[ 1]) 
2*pt(abs(z.value), df=df.w, lower.tail=F) 
#knockout-type 
ramda.w=c(I,I,O,O,-I,-I,O,D) 
n umer=t( ramda. w)% *%as. n umeric( integrate2. nlme$coeffic ients$ fixed) 




df. w==as.numeric( integrate2.nlme$fixDF$X[ I» 





wi=which( unlist(gregexpr("W" ,aa» !=-I ) 
ki=which(unlist(gregexpr("K",aa))!=-I) 
wrate.mat=mydata.mat[ wi,] 
krate. mat=mydata. mat[ki,] 
plot(mydata.g$time,mydata.g[,5],ylab="Heat Rate (8PM)", 
xlab="Time (min)",type="n",xlim=c(I,79» 
for(i in I :7){ 
points( c( 1:78), wrate.mat[i,],col=2,type="o",lwd=1 ,pch=l) 
points( c(1 :78),krate.mat[i,],col=4,type="o" ,lwd=2,pch= I) 
legend("bottomright" ,c("WT" ,"KO"),col=c(2,4 ),Ity=c( 1,1)) 
# lines (c(l :78),wrate.mat[i,],col=2) 
abline(v=c(5,33),1ty=2) 
abline(v=c(5,33 ),1ty=2) 
arrows(l3,450, 5,450, length = 0.1) 
arrows(27,450, 32.5,450,length = 0.1) 
text(20,450, "Ischemia") 
arrows(45,450, 33.5,450, length = 0.1) 
arrows(66,450, 80,450,length = 0.1) 
text(56,450, "Reperfusion") 
##preischemic period## 
pre. isch<-subset( mydata.g,period="preisch") 
mydata. preisch. g<-grou pedData(Rate-timeJsubject,pre. isch) 
plot( mydata.preisch.g,outer=-type,aspect= I, 
xlab="Time (min)-preischemic period",ylab="Heart Rate (8PM)") 
mydata.mat<-asTable(mydata.preisch.g) 
al =rownames(mydata.mat) 
wi=which(unlist(gregexpr("W",a I »!=-I) 
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for(i in J:7){ 
points( c( 1 : 5), wrate.mat[ i,],col=2,type="o" ,Iwd= 1 ,pch= I) 
points( c( 1 :5 ),krate.mat[ i,],col=4,type="o" ,lwd=2,pch= I) 
# lines (c(l :5),wrate.mat[i,],col=2) 
legend("topright" ,c("WT", "KO"),col=c(2,4 )"Iwd=c( 1 ,2),Ity=c( 1,1» 
##ischemic period## 
isch<-subset(mydata.g,period=="isch") 
#write.csv( isch,file="rate _ isch.csv") 
mydata.isch.g<-groupedData(Rate-timelsubject,isch) 
plot( mydata.isch.g,outer=-type,aspect= 1, 
xlab="Time(min)-Ischemic period",ylab="Heart Rate(BPM)") 
mydata.mat<-asTable(mydata.isch.g) 
a2=rownames( mydata. mat) 






for(i in 1 :7){ 
points(c(6:33),wrate.mat[i,],col=2,type="o",lwd=l,pch=l) 
points( c( 6:33 ),krate.mat[ i,],col=4 ,type="o" ,lwd=2,pch= I) 
# lines (c(6:33),wrate.mat[i,],col=2) 
legend("topright" ,c("WT"," KO" ),col=c(2,4 ),Iwd=c( 1,2 ),Ity=c( 1,1)) 
##reperfuaion period## 
reper<-su bset( mydata. g,period== "reper") 
mydata.reper.g<-groupedData(Rate-timelsubject,reper) 
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plot( mydata.reper.g,outer=-type,aspect= I, 
xlab="Time (min)-reperfusion period",ylab="Heart Rate (BPM)", 
mydata.mat<-asTable(mydata.reper.g) 
a3=rownames(mydata.mat) 
wi=which( unlist(gregexpr("W" ,a3) )!=-I) 
ki=which( unlist(gregexpr("K" ,a3» !=-I) 
wrate. mat=mydata.mat[ wi,l 
krate.mat=mydata.mat[ki,l 
plot(mydata.reper.g$time,mydata.reper.g$Flow,xlab="Time (min)-reperfusion period",ylab="Heart Rate(BPM)",type="n") 
for(i in I: 7){ 
points( c(34 :78), wrate.mat[i,l,col=2,type="o" ,lwd= 1 ,pch= I ) 
points( c(34 :78),krate.mat[ i,j,col=4,type="o" ,lwd=2,pch= I) 
legend("bottomright" ,c("WT", "KO"),col=c(2,4 )"lwd=c( 1,2 ),Ity=c( 1,1» 
######################################### 













plot(augPred(prel.lme),grid = T, 












summary( isch l.lme) 
anova( isch.lme,isch l.lme) 
###Reperfusion period### 
per<-subset(mydata.g,period="reper") 






plot(augPred(perl.lme),grid = T, 
xlab="Time(min)- Reperfusion period",ylab="Flow (mLlmin)") 
plot(per) 
### The integrated model for coronary flow ### 
pre. isch. per<-mydata.g 
pre.isch.per = pre.isch.per[-970,] 
plot(pre. isch. per) 
plot(pre. isch. per,outer=-type,aspect= I ,xlab="Time (min)", 
ylab="Flow (mLlmin)") 
flow.pd <- function(Cl,C2,C3,C4,C5,C6,C7,time){ 
C I *( time<=5 )+C2 *( time>5 & time<=33 )+(C3+( C4-C3 )*exp( -exp( C5)*( time-34) )-C7*( exp( -exp(C5)*( time-34) )-exp(-
exp(C6)*( time-34») )*( time> 33) 
pd <- function(para,time=0:45){ 
flow. pd(C I =para[ I ],C2=para[2],C3=para[3],C4=para[ 4],C5=para[5],C6=para[ 6],C7=para[7],time=time) 
vstart = c(4,O,2.48,4,-O.92,-O.86,2.5) 
td = na.omit(pre.isch.per) 
id = unique(td$subj) 
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min,time = min(td$time) 
allpar = cO 
for(i in 1 :Iength(id»)( 
aa = td[td$subj==id[i],] 
#aa$time = aa$time - min,time 
fun <- function(par)( 
fit = pd(para=par,time=aa$time) 
11= sum( (aa$Flow-fit)1\2 ) 
II 
fit = nlminb( start=( vstart ),fun) 
pred = pd(fit$par,time=seq(O, 1 OO,by=, I» 
dev,newO 
plot( seq(O, 1 OO,by=, 1 ),pred,col=2,type="I" ,ylim=c(O,max(td$Flow») 
points( aa$time,aa$Flow) 
title(paste("S ubj:" ,id[ i],sep=" "» 
allpar = rbind(allpar,fit$par) 
nstart = apply(allpar,2,mean) 
integrate,r<-nlme(Flow-flow, pd(C 1 ,C2,C3 ,C4,CS ,C6,C7 ,time), 
fixed = C l+C2+C3+C4+CS+C6+C7-type, 
random = (CI+C2+C3+C4+CS+C6+C7-1), 




control=list( maxIter=S,pnlsMaxIter=S ,tolerance= 1 ,niterEM= 1 O,pnlsTol= 1 ,msTol=O.S), 
data=td 















df. w=as.numeric( integrate.r$fixDF$X[ 1]) 
2*pt(abs(z.value), df=df.w, lower.tail=F) 
#knockout-type 





df. w=as.numeric( integrate.r$fixDF$X[ I]) 











for(i in 1 :7){ 
points( c( I :78), wrate.mat[i,],col=2,type=" 0" ,Iwd= 1 ,pch= 1) 
points( c( I :78),krate.mat[i,],col=4 ,type="o" ,lwd=2,pch= 1) 
legend("bottomright" ,c("WT", "KO"),col=c(2,4 ),Ity=c( 1,1)) 






plot( mydata. preisch.g,outer=-type,aspect= 1 ,xlab="Time (min)-Preischemic period", 
ylab="Flow (mLlmin)") 
mydata.mat<-asTable(mydata.preisch.g) 
a 1 =rownames( mydata.mat) 
wi=which(unlist(gregexpr("W",a 1 »!=-I) 




xlab="Time (min) - Preischemic period", 
ylab="Flow (mLlmin)",type="n") 
for(i in I :7){ 
points( c(l :5),wrate.mat[i,],col=2,type="o" ,lwd=1 ,pch=l) 
points( c(1 :5),krate.mat[i,],col=4,type="o" ,lwd=2,pch=l) 
# lines (c(\ :5),wrate.mat[i,],col=2) 












plot(mydata.isch.g$time,mydata.isch.g$Flow,xlab="Time (min)- Ischemic period", 
ylab="Flow (mLlmin)",type="n") 
for(i in 1 :7){ 
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points( c( 6:33), wrate.mat[ i,],col=2,type="o" ,lwd= I ,pch= I) 
points( c( 6:33 ),krate.mat[i,],col=4,type="o" ,lwd=2,pch= I) 
# lines (c(6:33),wrate.mat[i,],col=2) 
legend( "topright" ,c( "WT", "KO" ),col=c(2,4 ),lwd=c( 1,2 ),lty=c( I, I » 
##reperfuaion period 
reper<-subset( mydata. g,period==" reper") 
mydata.reper.g<-groupedData(Flow-timelsubject,reper) 








plot(mydata.reper.g$time,mydata.reper.g$Flow,xlab="Time (min)- Reperfusion period", 
ylab="Flow (mLlmin)",type="n") 
for(i in 1:7){ 
points(c(34:78),wrate.mat[i,],col=2,type="o",lwd=l,pch=I) 
points( c(34 :78 ),krate.mat[i,],col=4 ,type="o" ,lwd=2,pch= I) 
legend("bottomright" ,c("WT", "KO"),col=c(2,4 )"lwd=c( 1 ,2 ),lty=c( I, I» 
########################################## 




mydata.g$type <- relevel(mydata.g$type, ref="Wild") 
contrasts( mydata.g$type) 
###Reperfusion period### 
per<-s u bset( mydata. g,peri od= "reper") 
plot(per,outer=-type,aspect= I ,xlab="Time (min)- Reperfusion period", 
ylab="DEVELOPED (mmHg)") 
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t.pd <- function(CI,C2,C3,C4,time){ 
C 1 *( time<=C2) + (C i +C3 *(l-exp( -exp( C4 )*( time-C2))) )*( time>=C2) 
pd <- function(para,time){ 
t. pd(para[ 1 ],para[2 ],para[3 ],para[ 4j,time=time) 
vstart = c(0,43,l,0) 
td = na.omit(per) 
id = unique(td$subj) 
allpar = cO 
for(i in 1 :length(id)){ 
aa = td[td$subj==id[ij,j 
fun <- function(par){ 
fit = pd(para=par,time=aa$time) 
11= sum( (aa$DEVELOPED-fit)"2 
II 
fit = nlminb(start=(vstart),fun) 
pred = pd(fit$par,time=seq(34,78,by=.I)) 
dev.newO 
plot(seq(34, 78,by=.1 ),pred,col=2,type="I",ylim=c(0,44)) 
points(aa$time,aa$DEVELOPED) 
titIe(paste("Subj:" ,id[ ij,sep="")) 
allpar = rbind(allpar,fit$par) 
n 1 start = apply(allpar,2,mean) 
cpt.nlme<-nlme(DEVELOPED-t.pd(CI,C2,C3,C4,time), 
fixed= C I+C2+C3+C4 -type, 
random = CI+C2+C3+C4 -I, 
start=c(C 1 =n 1 start[ Ij,0,C2=n Istart[2j,0,C3=n 1 start[3j,0,C4=nistart[4j,0), 
# groups=-type, 
summary( cpt.nlme) 
control=list(maxlter= 1 O,pnlsMaxlter= 1 O,tolerance=O.I,niterEM=1 O,pnlsTol=1 ,msTol=O.I), 
data=td) 
plot(augPred(cpt.nlme,level = O:l),grid = T,ylab="DEVELOPED (mmHg)", 
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ramda. w=c(O,O,O, I ,0,0,0,0) 




df w=as.numeric( integrate.r$fixDF$X[ I]) 







df w=as.numeric(integrate.r$fixDF$X[ I]) 










ylab="LV developed pressure (mmHg)",type="n",xlim=c(l,79» 
for(i in 1 :7){ 
points( c( 1 :78), wrate.mat[ i,],col=2,type="o" ,Iwd= 1 ,pch= 1) 
points( c( 1 :78),krate.mat[i,],col=4,type="o" ,lwd=2,pch= I) 
legend("topright" ,c("WT"," KO"),col=c(2,4 ),lty=c( 1,1» 
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# lines (c(l :78),wrate.mat[i,],col=2) 
abline( v=c( 5 ,33 ),lty=2) 
##reperfusion period## 
reper<-s u bset( mydata. g,period==" reper") 
mydata.reper.g<-groupedData(DEVELOPED-timelsubject,reper) 
plot(mydata.reper.g,outer=-type,aspect= 1 ,xlab="Time (min)- Reperfusion period", 







plot(mydata.reper.g$time,mydata.reper.g$Flow,xlab="Time (min)- Reperfusion period", 
ylab="LV developed pressure (mmHg)",type="n") 
for(i in 1 :7){ 
points( c(34 :78), wrate.mat[ i,],col=2,type="o" ,Iwd= 1 ,pch= I) 
points( c(34 :78 ),krate.mat[ i,],col=4 ,type="o" ,lwd=2,pch= 1 ) 
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